Warburg Pincus is a global private equity firm, established in 1966, with over $60 billion in assets under management. Based in New York, it has offices worldwide and invests in a diverse range of sectors, including energy, financial services, healthcare, technology, and real estate. The firm focuses on growth investing, typically committing between $20 million to $1 billion per transaction, and has an average investment period of five to seven years. Warburg Pincus seeks to partner with management teams to build sustainable companies, often taking a board seat and investing as a lead investor.
9th Floor, China World Tower 1 1 Jianguomenwai Avenue, Beijing 100004, China
Issam Abedin
Principal, Technology
Saurabh Agarwal
Managing Director and Head of Southeast Asia Private Equity
Cole Agbede
Associate
Jonas Agesand
Managing Director, Member of ESG Committee and Board Member of EPER of Invest Europe
José Arredondo
Vice President
Arjjun Balasubramanian
Associate
David A. Barr
Managing Director
Matt Bashaw
Vice President, Capital Markets
Carl Baumbach
Principal
Cem Behmoaram
Principal
Roy Ben-Dor
Managing Director
Beatrice Bianchi
Associate
Noah Bishop
Principal
Rob Buonanno
Managing Director, Capital Markets
Maximilian Buttinger
Associate
Thomas Carella
Managing Director and Head of Healthcare Group
Richard Chan
Executive Director
Victoria Chao
Associate, Technology
Olivia Chen
Managing Director
Ruoxi Chen
Managing Director, Healthcare
Julie Cheng
Vice President
Vikram Chogle
Vice President and Principal
Enzo Ciantelli
Principal
Mark Colodny
Managing Director
David Coulter
Special Limited Partner
Timothy J. Curt
Managing Director, Finance
Shalin Dalal
Private Equity Vice President
Ryan Dalton
Principal
Cary J. Davis
Managing Director
Peter Deming
Managing Director
Sanjay Dholakia
Senior Vice President
Michael Dimitrief
Vice President
Gordon Ding
Principal, Partner and Managing Director
Nevio Duci
Vice President
Tony Eales
Managing Director
Min Fang
Managing Director and Co-Head of China Private Equity
Adrienne C. Filipov
Chief Human Capital Officer, Managing Director
Jonathan Finer
Senior Vice President, Political Risk and Public Policy / Environmental, Social and Governance, Investment Support
Max Fowinkel
Managing Director
Michael Frain
Managing Director, Shared Services and member of the Environmental, Social and Governance Committee
Eric Friedman
Managing Director
Frances Fukuda
Director
Bradford Garvey
Principal, Capital Markets
Timothy F. Geithner
President
Stephanie Geveda
Head of Business Services and Managing Director
Alberto Ghezzi
Vice President
Steven Glenn JD
Managing Director
Yen Goh
Senior Vice President
Greta Gu
Investment Manager
David Habachy
Managing Director
Fred Hassan
Partner and Managing Director
Hector Herrera
Associate, Strategic Investments group
Ikram Hoque
Associate, Healthcare and Consumer
Hugo Hu
Executive Director
Jeffrey Hu
Principal
In Seon Hwang
Managing Director
Faisal Jamil
Managing Director
Rebecca Jin
Vice President
Carolina Joyce
Principal, Industrial Service Investments
Sandeep Kagzi
Principal
Chip Kaye
CEO
Peter Kimmey
Principal
Robert Kirkham
Vice President
Adam Krainson
Principal
Henry Kressel Ph.D
Special Limited Partner
Amr Kronfol
Managing Director
Kanika Kumar
Managing Director and Member, Council for Diversity, Equity and Inclusion
Zach Lazar
Managing Director
Zachary Lazar
Managing Director, Industrial Investments
Terence Lee
Principal, Investments Southeast Asia
King Leung
Vice President
James R. Levy
Managing Director, Energy
Amy Li
Investment Director
Bob Lian
Principal and Executive Director
Christopher Liebig
Associate
Natasha Lim
Associate, Technology
Michael Lim
Associate, Technology, Media and Telecommunications
Samuel Lipsick
Principal, Investments
Jeffrey Luse
Principal
Vishal Mahadevia
Managing Director
Bruno Maimone
Principal
Pranav Manoharan
Vice President
Dennis Mao
Principal, Technology, Media and Telecommunications
Nancy Martin
Managing Director
Benny Melumad
Managing Director, Digital Strategy and Innovation
Vishnu Menon
Managing Director
Hemant Mundra
Principal
Henrique Muramoto
Managing Director
Doug Musicaro
Principal
Lucas Mussi
Vice President
James Neary
Managing Director, Co-Head of US Private Equity and Member of the Executive Management Group
Himanshu Nema
Principal
James O’Gara
Managing Director
Sina Oefinger
Vice President
Andrew Park
Managing Director and Co-Leads HCIT
Chan Ho Park
Principal
Jeffrey Perlman
President and Member of the Executive Management Group
Michael Picasso
Vice President
Flavio Porciani
Managing Director
Angel Pu
Principal
Leela Ramnath
Managing Director, Global Head of Sustainability Strategy
David Reis
Principal
Tobias Reitz
Principal, Financial Service
Werner Rickinger
Associate
Julia Roberts
Managing Director and Global Head of Product
Alexander Roso
Principal, Business Services
John Rowan
Managing Director
Justin Sadrian
Managing Director
Anish Saraf
Managing Director
Adarsh Sarma
Managing Director
Viraj Sawhney
Managing Director
Todd Schell
Principal
Hutomo Setiawan
Principal
Chris Shen
Principal
Adam Sherman
Principal
Leo Shi
Managing Director, Healthcare Investments
Angel Shum
Principal, Technology
Andrew Sibbald
MD and Head of Europe
Jake Siewert
Managing Director and Head, Global Public Policy and Political Risk
Swapnil Sinha
Principal
Ashutosh Somani
Managing Director
David Sreter
Managing Director
Cary Stathopoulos
Vice President
Danielle Steinman
Vice President, Technology
Alex Stratoudakis
Principal
Jake Strauss
Managing Director
Jacob Strauss
Principal
Jake Swinghamer
Associate, Healthcare Investments
Mike Thompson
Partner and Managing Director
Henner Thormaehlen
Vice President, Healthcare, Industrial and Business Services, Technology
Carla Tuan
Associate
Maiju Varhe
Associate
Pranav Verma
Principal, Healthcare
Ashton Wackym
Associate, Industrial and Business Services
Nick Smith Wang
Principal
Danli Wang
Executive Director
Elizabeth H. Weatherman
Managing Director
Frank Z. Wei
Managing Director
Kevin White
Vice President
Patrick Wilsey
Vice President, Healthcare
Rory Woodhouse
Associate
Daniel Xiong
Principal, Healthcare
Roland Xu
Managing Director and CFO, North Asia
Vera Yang
Managing Director and Partner
Jeremy Young
Managing Director
Zhiming Yue
Managing Director
Daniel Zamlong
Managing Director
Jennifer Zhang
Executive Director
Qiqi Zhang
Principal and Executive Director
Jericho Zhang
Partner
John Zhang
Managing Director
Stephenie Zhang
Technology Investor
Ben Zhou
Principal
Amanda Zhou
Vice President, Healthcare Investments
Lilian Zhu
Vice President
Lauren Zletz
Managing Director
Max Hadi Ongko Wijaya
Vice President
T. J. Carella
Managing Director
Tarik-Timo Ghoniem
Vice President, Investments
Lee Becker
Managing Director
Past deals in Hospital
New Frontier Group
Secondary Market in 2025
New Frontier Group, established in 2016 and headquartered in Hong Kong, is a private equity firm primarily focused on investing in the healthcare sector in China. The company operates through its subsidiary, New Frontier Health Corp, which provides comprehensive, premium healthcare services throughout the patient lifecycle. New Frontier Health operates a network of hospitals and clinics, including 24/7 emergency rooms, intensive care units, operating rooms, and diagnostic services, across various regions in China. The company's portfolio spans five hospitals and eight clinics in northern China, two hospitals and four clinics in eastern China, and two hospitals and two clinics in southern China.
Xunyen A
Private Equity Round in 2024
Xunyen A is a group of hospital that focuses on medical services and advanced treatment methods.
Ensemble Health Partners
Private Equity Round in 2022
Ensemble Health Partners is a comprehensive revenue cycle management company that supports over 250 healthcare providers nationwide. By offering a full suite of technology-enabled services, Ensemble manages the entire revenue cycle for health systems, including hospitals and affiliated physician groups. Their platform includes revenue cycle outsourcing and a variety of healthcare financial management services, which aim to enhance financial outcomes while improving patient experiences. This holistic approach allows healthcare providers to concentrate on delivering exceptional care to their communities.
MedPlus
Private Equity Round in 2021
MedPlus Health Services Pvt. Ltd. is a prominent pharmacy retail chain in India, founded in 2006 in Hyderabad. The company operates over 1,400 pharmacies across the country, serving more than 250,000 customers daily. MedPlus offers a wide range of products, including prescription medications, over-the-counter medicines, vitamins, and personal care items. In addition to its physical stores, MedPlus has developed a significant online presence through its e-pharmacy platform, MedPlusMart.com, which allows customers to conveniently order products, access health records, and view prescription histories. The company also provides laboratory testing services and distributes pharmaceuticals and medical consumables to healthcare providers, ensuring a comprehensive approach to health and wellness. MedPlus is committed to sourcing high-quality medicines from reliable suppliers, thus enhancing customer trust and safety in the pharmaceutical market.
CityMD
Acquisition in 2017
CityMD is a prominent urgent care provider operating a network of clinics throughout the greater New York area. The company focuses on delivering efficient and high-quality medical care through a patient-centric approach. CityMD offers a comprehensive range of healthcare services, including treatment for injuries and illnesses, rapid lab tests and screenings, vaccinations, physical exams, and pediatric care. By emphasizing personalized attention and accessibility, CityMD aims to meet the diverse healthcare needs of its patients in a convenient and timely manner.
UIB
Private Equity Round in 2016
UIB is a leading Chinese obstetrics, gynecology and pediatrics hospital chain headquartered in Shanghai. UIB currently owns the UIB International Postpartum Care Center and the Ruizhitang Women’s Healthcare Center, and plans to launch the Shanghai Everbetter Maternity Hospital and the Shanghai Everbetter Pubin Children’s Hospital in 2016.
Metropolis Healthcare
Venture Round in 2010
Metropolis Healthcare is a leading diagnostic company based in Mumbai, India, recognized for its extensive service menu that includes over 4,500 types of tests. With 34 years of experience, the company processes approximately 15 million tests annually, serving more than 10,000 laboratories, hospitals, nursing homes, and 200,000 doctors across the country. Metropolis is accredited by both the National Accreditation Board for Testing and Calibration Laboratories and the College of American Pathologists, underscoring its commitment to quality and accuracy. In addition to its core pathology services, Metropolis has diversified its offerings over the past decade to include clinical trials, hospital lab management, home health services, preventive health check-ups, and corporate wellness solutions. This expansion reflects the company's dedication to advancing healthcare diagnostics in India and enhancing patient care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.